A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Avastin (bevacizumab): Counterfeit Product – FDA Issues Letters to 19 Medical Practices. According to the Food & Drug Administration FDA’s MedWatch:
The counterfeit version of Avastin does not contain the medicine’s active ingredient, bevacizumab, which may have resulted in patients not receiving needed therapy.
For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Avastin (bevacizumab): Counterfeit Product – FDA Issues Letters to 19 Medical Practices.
To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.
If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.